Porimol Palma

Bangabandhu Sheikh Mujib Medical University (BSMMU) has already completed trial of the Gonoshasthaya Kendra-developed antibody test and may submit its report to the drug administration by Wednesday.

“The committee concerned is now processing data of the antibody kit’s performance trial. We think we can submit the report by Wednesday,” BSMMU Vice Chancellor Prof Kanak Kanti Barua told The Daily Star yesterday.

Gonoshasthaya Kendra officials say they are eagerly waiting for the report to be submitted to the Directorate General of Drug Administration (DGDA) and then for registration, which can allow mass production and distribution of the kit -- GR-Rapid Dot Blot.